Regulation of transplantation tolerance by T-cell growth factors
暂无分享,去创建一个
T. Strom | X. Li | Yongsheng Li | X. Zheng
[1] T. Strom,et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.
[2] T. Strom,et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance , 1999, Nature Medicine.
[3] D. Baltimore,et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. , 1999, Immunity.
[4] C. Martínez-A,et al. An IL‐2 receptor β subdomain that controls Bcl‐XL expression and cell survival , 1999 .
[5] T. Strom,et al. Induction of allograft tolerance in the absence of Fas-mediated apoptosis. , 1999, Journal of immunology.
[6] K. Wood,et al. Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. , 1999, Journal of immunology.
[7] J. Ihle,et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. , 1999, Immunity.
[8] T. Dassopoulos,et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.
[9] J. Tschopp,et al. Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.
[10] W. Fiers,et al. Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. , 1998, Journal of immunology.
[11] Z. Dai,et al. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. , 1998, Journal of immunology.
[12] Chyung-Ru Wang,et al. Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.
[13] M. Zand,et al. Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. , 1998, Transplantation.
[14] P. Nickerson,et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. , 1998, Journal of immunology.
[15] K. Muegge,et al. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. , 1998, Journal of immunology.
[16] C. Orosz,et al. Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns. , 1998, Transplantation.
[17] J. Tschopp,et al. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. , 1998, Immunity.
[18] J. Sprent,et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.
[19] L. Zheng,et al. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. , 1998, Journal of immunology.
[20] B. Ludviksson,et al. TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. , 1997, Journal of immunology.
[21] R. Paus,et al. Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.
[22] B. Burgering,et al. Phosphatidylinositol 3-Kinase Links the Interleukin-2 Receptor to Protein Kinase B and p70 S6 Kinase* , 1997, The Journal of Biological Chemistry.
[23] P. Linsley,et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. , 1997, Journal of immunology.
[24] T. Strom,et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Strom,et al. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. , 1996, Journal of immunology.
[26] J. Phillips,et al. T cell regulation in adult transplantation tolerance. , 1996, Journal of immunology.
[27] T. Waldmann,et al. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.
[28] Kendall A. Smith,et al. Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.
[29] R. Dubose,et al. Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.
[30] P. Nickerson,et al. IL-2 knockout recipient mice reject islet cell allografts. , 1995, Journal of immunology.
[31] S. Burdach,et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.
[32] W. Leonard,et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.
[33] J. Johnston,et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.
[34] R. Lechler,et al. Presentation and recognition of major and minor histocompatibility antigens. , 1994, Transplant immunology.
[35] J. Renauld,et al. Thymic lymphomas in interleukin 9 transgenic mice. , 1994, Oncogene.
[36] K. Rajewsky,et al. Generation and analysis of interleukin-4 deficient mice. , 1991, Science.
[37] M. Lenardo. lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.
[38] E. Shevach,et al. Interleukin 7 is a T-cell growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[39] N. Tanaka,et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. , 1996, Annual review of immunology.
[40] J. Renauld,et al. Interleukin-9: a T-cell growth factor with a potential oncogenic activity. , 1993, Cancer investigation.
[41] S. Schreiber,et al. The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.
[42] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.